Diazoxide Suspension
NDC Package 13517-100-30
Package Information
Diazoxide suspension is diazoxide Oral Suspension is indicated for the management of hypoglycemia due to hyperinsulinism associated with the following conditions:Adults: Inoperable islet cell adenoma or carcinoma, or extrapancreatic malignancy.Infants and Children: Leucine sensitivity, islet cell hyperplasia, nesidioblastosis, extrapancreatic malignancy, islet cell adenoma, or adenomatosis. This formulation utilizes a suspension delivery system. Marketed by E5 Pharma, Llc, this product is identified by NDC 13517-100 and is authorized under FDA application ANDA211050.
Identification & Billing
- RxCUI: 197593 - diazoxide 50 MG in 1 mL Oral Suspension
- RxCUI: 197593 - diazoxide 50 MG/ML Oral Suspension
- RxCUI: 197593 - diazoxide 50 MG per 1 ML Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 13517 - E5 Pharma, Llc
- 13517-100 - Diazoxide
- 13517-100-30 - 1 BOTTLE, DROPPER in 1 CARTON / 30 mL in 1 BOTTLE, DROPPER
- 13517-100 - Diazoxide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 13517-100-30 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 30 ml in 1 bottle, dropper of Diazoxide, a human prescription drug labeled by E5 Pharma, Llc. This suspension is formulated for oral use and contains diazoxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by E5 Pharma, Llc on December 11, 2019. The current certification is valid through December 31, 2026.
How is this E5 Pharma, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 13517010030. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.